Welcome to LookChem.com Sign In|Join Free

CAS

  • or
1-(1H-benzimidazol-2-yl)-ethylamine; dihydrochloride is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

2503155-57-3

Post Buying Request

2503155-57-3 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

2503155-57-3 Usage

Class

Benzimidazole

Function

Broad-spectrum anthelmintic agent

Mechanism of Action

Interferes with the parasite's ability to absorb glucose, leading to its death

Salt Form

Dihydrochloride

Solubility

More water-soluble than the base form

Administration

Easier to administer and absorb in the body due to increased water solubility

Applications

Treats infections caused by roundworms, tapeworms, and other parasites in humans and animals

Precautions

Should be used with caution and under the guidance of a medical professional

Side Effects

Can cause side effects

Drug Interactions

Can interact with other medications

Check Digit Verification of cas no

The CAS Registry Mumber 2503155-57-3 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 2,5,0,3,1,5 and 5 respectively; the second part has 2 digits, 5 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 2503155-57:
(9*2)+(8*5)+(7*0)+(6*3)+(5*1)+(4*5)+(3*5)+(2*5)+(1*7)=133
133 % 10 = 3
So 2503155-57-3 is a valid CAS Registry Number.

2503155-57-3Downstream Products

2503155-57-3Relevant articles and documents

BENZIMIDAZOLE COMPOUNDS THAT ARE VITRONECTIN RECEPTOR ANTAGONISTS

-

Page/Page column 30-31, (2008/06/13)

The present invention provides compounds having formula (I) wherein n, p, q and r are each independently selected from 0 or 1; a, b, c, and d each independently represents a carbon or nitrogen atom, with the proviso that no more than two of a, b, c, and d are nitrogen atoms; Y and Y' each independently represents 1-4 optional substituents selected from alkyl, alkoxy, halo, -CF3, and -C(O)OH; R, R, R and R are H or specified substituents; R, R, R, R, R, R, R and R are independently selected from H or C1-C3 alkyl; or a biolabile ester thereof, or a pharmaceutically acceptable salt thereof. Also provided are methods of using these compounds for treating vitronectin-mediated disorders, e.g., cancer, retinopathy, artherosclerosis, vascular restenosis, and osteoporosis.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 2503155-57-3